CYCSP35

Across TCGA pan-cancer cohorts, CYCSP35 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of CYCSP35’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where CYCSP35 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CYCSP35 is over-expressed in tumor.

LUAD are the cancer types where CYCSP35 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CYCSP35 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	All	+0.057	.004	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

CYCSP35–LUAD

Open the LUAD breakdown →